These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22103064)

  • 1. Nanomedicine-nanoemulsion formulation improves safety and efficacy of the anti-cancer drug paclitaxel according to preclinical assessment.
    Lee KC; Maturo C; Rodriguez R; Nguyen HL; Shorr R
    J Nanosci Nanotechnol; 2011 Aug; 11(8):6642-56. PubMed ID: 22103064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapeutic vitamin E nanoemulsion synergies the antiproliferative activity of paclitaxel in breast cancer cells via modulating Th1 and Th2 immune response.
    Pawar VK; Panchal SB; Singh Y; Meher JG; Sharma K; Singh P; Bora HK; Singh A; Datta D; Chourasia MK
    J Control Release; 2014 Dec; 196():295-306. PubMed ID: 25459427
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics, tissue distribution and anti-tumour efficacy of paclitaxel delivered by polyvinylpyrrolidone solid dispersion.
    Liu X; Sun J; Chen X; Wang S; Scott H; Zhang X; Zhang Q
    J Pharm Pharmacol; 2012 Jun; 64(6):775-82. PubMed ID: 22571255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics, biodistribution, efficacy and safety of N-octyl-O-sulfate chitosan micelles loaded with paclitaxel.
    Zhang C; Qu G; Sun Y; Wu X; Yao Z; Guo Q; Ding Q; Yuan S; Shen Z; Ping Q; Zhou H
    Biomaterials; 2008 Mar; 29(9):1233-41. PubMed ID: 18093646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement of cellular uptake, in vitro antitumor activity and sustained release profile with increased bioavailability from a nanoemulsion platform.
    Choudhury H; Gorain B; Karmakar S; Biswas E; Dey G; Barik R; Mandal M; Pal TK
    Int J Pharm; 2014 Jan; 460(1-2):131-43. PubMed ID: 24239580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel-loaded hyaluronan solid nanoemulsions for enhanced treatment efficacy in ovarian cancer.
    Kim JE; Park YJ
    Int J Nanomedicine; 2017; 12():645-658. PubMed ID: 28176896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved safety and efficacy of a lipid emulsion loaded with a paclitaxel-cholesterol complex for the treatment of breast tumors.
    Ye J; Liu Y; Xia X; Meng L; Dong W; Wang R; Fu Z; Liu H; Han R
    Oncol Rep; 2016 Jul; 36(1):399-409. PubMed ID: 27175803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy.
    Sharma D; Chelvi TP; Kaur J; Chakravorty K; De TK; Maitra A; Ralhan R
    Oncol Res; 1996; 8(7-8):281-6. PubMed ID: 8938791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An optimized two-vial formulation lipid nanoemulsion of paclitaxel for targeted delivery to tumor.
    Chen L; Chen B; Deng L; Gao B; Zhang Y; Wu C; Yu N; Zhou Q; Yao J; Chen J
    Int J Pharm; 2017 Dec; 534(1-2):308-315. PubMed ID: 28986321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety against nephrotoxicity in paclitaxel treatment: Oral nanocarrier as an effective tool in preclinical evaluation with marked in vivo antitumor activity.
    Choudhury H; Gorain B; Tekade RK; Pandey M; Karmakar S; Pal TK
    Regul Toxicol Pharmacol; 2017 Dec; 91():179-189. PubMed ID: 29080846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel Water-Borne Polyurethane Nanomicelles for Cancer Chemotherapy: Higher Efficiency of Folate Receptors Than TRAIL Receptors in a Cancerous Balb/C Mouse Model.
    Ajorlou E; Khosroushahi AY; Yeganeh H
    Pharm Res; 2016 Jun; 33(6):1426-39. PubMed ID: 26908046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypersensitivity reaction studies of a polyethoxylated castor oil-free, liposome-based alternative paclitaxel formulation.
    Wang H; Cheng G; Du Y; Ye L; Chen W; Zhang L; Wang T; Tian J; Fu F
    Mol Med Rep; 2013 Mar; 7(3):947-52. PubMed ID: 23291923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin enhances oral bioavailability and anti-tumor therapeutic efficacy of paclitaxel upon administration in nanoemulsion formulation.
    Ganta S; Devalapally H; Amiji M
    J Pharm Sci; 2010 Nov; 99(11):4630-41. PubMed ID: 20845461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PEG liposomalization of paclitaxel improved its in vivo disposition and anti-tumor efficacy.
    Yoshizawa Y; Kono Y; Ogawara K; Kimura T; Higaki K
    Int J Pharm; 2011 Jun; 412(1-2):132-41. PubMed ID: 21507344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polyelectrolyte stabilized multilayered liposomes for oral delivery of paclitaxel.
    Jain S; Kumar D; Swarnakar NK; Thanki K
    Biomaterials; 2012 Oct; 33(28):6758-68. PubMed ID: 22748771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free paclitaxel loaded PEGylated-paclitaxel nanoparticles: preparation and comparison with other paclitaxel systems in vitro and in vivo.
    Lu J; Chuan X; Zhang H; Dai W; Wang X; Wang X; Zhang Q
    Int J Pharm; 2014 Aug; 471(1-2):525-35. PubMed ID: 24858391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced antitumor efficacy by paclitaxel-loaded pluronic P123/F127 mixed micelles against non-small cell lung cancer based on passive tumor targeting and modulation of drug resistance.
    Zhang W; Shi Y; Chen Y; Yu S; Hao J; Luo J; Sha X; Fang X
    Eur J Pharm Biopharm; 2010 Aug; 75(3):341-53. PubMed ID: 20451605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PEG-derivatized octacosanol as micellar carrier for paclitaxel delivery.
    Chu B; Qu Y; Huang Y; Zhang L; Chen X; Long C; He Y; Ou C; Qian Z
    Int J Pharm; 2016 Mar; 500(1-2):345-59. PubMed ID: 26794876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Superior therapeutic profile of poly-L-glutamic acid-paclitaxel copolymer compared with taxol in xenogeneic compartmental models of human ovarian carcinoma.
    Auzenne E; Donato NJ; Li C; Leroux E; Price RE; Farquhar D; Klostergaard J
    Clin Cancer Res; 2002 Feb; 8(2):573-81. PubMed ID: 11839679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and significance of heparin binding-epidermal growth factor-like growth factor in paclitaxel-resistant ovarian cancer].
    Tang X; Lu M; Li C; Deng S; Li M
    Zhonghua Fu Chan Ke Za Zhi; 2014 Jul; 49(7):517-22. PubMed ID: 25327734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.